Skip to main content
. 2021 Feb 18;13(4):856. doi: 10.3390/cancers13040856

Figure 2.

Figure 2

An overview of targeted therapies in GBM. Classification of current targeted therapies in GBM according to the three main signaling pathway alterations of the P53, Rb, and RTK pathways.